BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Lung cancer

1. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]